The Safety and Tolerability of WS016 in Healthy Chinese Volunteers
Status:
COMPLETED
Trial end date:
2023-06-15
Target enrollment:
Participant gender:
Summary
This clinic trial evaluates the safety and tolerability of single- and multiple- ascending doses of WS016 in healthy adult participants. There will be about 64 participants,48 active and 16 placebo.